Clinical Trial Update: Impact of Sacubitril/Valsartan on LV Diastolic Function in HFrEF

View source ↗

Summary

A clinical trial update examines how sacubitril/valsartan affects left ventricular diastolic function in patients with heart failure with reduced ejection fract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Assiut University | Conditions: Left Ventricular Diastolic Function | Status: NOT_YET_RECRUITING